USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark SOLOREL was filed as Word mark on 01/29/2009 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 12/15/2009.
The current status of the mark is "CANCELLED - SECTION 8".
| Trademark form | Word mark |
| File reference | 77658985 |
| Register number | 3724729 |
| Application date | January 29, 2009 |
| Publication date | June 30, 2009 |
| Entry date | December 15, 2009 |
Trademark owner
Weismullerstrasse 50
60314 Frankfurt am Main
DE
60314 Frankfurt am Main
DE
Trademark representatives
goods and services
5
Pharmaceutical preparations used for the treatment of cancer, pharmaceutical preparations administered as a radiosensitizer and used for the treatment of cancer, pharmaceutical preparations used for the treatment of urological diseases, pharmaceutical preparations used for the treatment of hormonal disorders, peptides-containing pharmaceutical preparations used for hormonal and tumors treatments, pharmaceutical preparations used for the treatment of endocrine diseases, pharmaceutical preparations used for the treatment of carcinoid tumors, pharmaceutical preparations used for the treatment of age-related diseases, pharmaceutical preparation used for the treatment of endometriosis, pharmaceutical preparations used for the treatment of uterine myoma, pharmaceutical preparations used for the treatment of non-malignant tumors, pharmaceutical preparation used for the treatment for benign prostatic hyperplasia (BPH), pharmaceutical preparations used as a tubulin inhibitor, pharmaceutical preparations based on LHRH antagonists platform for the treatment of cancer, cancer in combination with administered radiosensitizing, urological diseases, hormonal disorders, hormonal and tumor disorders, endocrine diseases,carcinoid tumors, age-related diseases, endometriosis, uterine myoma, non-malignant tumors and benign prostatic hyperplasia; pharmaceutical preparations used to induce apoptosis
ID: 1377658985